Skip to main content
. 2023 Jun 5;51(10):1318–1327. doi: 10.1097/CCM.0000000000005920

TABLE 2.

Summary of Secondary Endpoints in ICU Patients in the Two Groups

Variables Ciprofol (n = 88) Propofol (n = 45) Median of Difference, % (95% CI) p
Mean time to sedation (min) 57.5 ± 6.4 57.7 ± 6.7 0.00 (0.00–0.00) NA
Mean sedation compliance rate (%) 95.9 ± 10.6 96.2 ± 11.2 0.00 (0.00–0.00) NA
Extubation time
 From intubation or admitted to ICU (hr) 17.5 ± 9.8 16.4 ± 5.2 0.724
 From the drug withdrawal (hr) 1.1 ± 1.0 1.2 ± 1.1 0.718
Recovery time (min) 4.8 ± 9.8 1.6 ± 2.8 0.003
Usage of study drugs
 Duration of loading dose (min) 4.0 ± 0.4 4.0 ± 0.1 0.266
 Numbers of top-up dose (times) 0.0 ± 0.2 0.1 ± 0.6 0556
 Number of patients with ≥ 1 top-up dose, n (%) 2 (2.3) 1 (2.2) 1.000
 Duration of maintenance administration (hr) 9.8 ± 4.7 9.7 ± 4.7 0.968
 Number of dose adjustments during maintenance (times) 0.6 ± 1.2 0.6 ± 1.1 0.722
 Number of patients with ≥ 1 dose adjustment, n (%) 29 (33.0) 17 (37.8) 0.700
 Overall administration duration of study drugs (hr) 9.8 ± 4.7 9.8 ± 4.7 0.964
Remifentanil dose/min per body weight (μg/kg/min) 0.04 ± 0.03 0.04 ± 0.03 0.00 (–0.44 to 0.54) NA
Nursing scores (range, 0–12) 5.0 ± 1.5 5.2 ± 1.2 0.090

NA = not applicable.

Data are presented as the mean ± sd or numbers with percentages.